Compounds > isomethyleugenol
Page last updated: 2024-08-18

isomethyleugenol and Prostatic Neoplasms, Castration-Resistant

isomethyleugenol has been researched along with Prostatic Neoplasms, Castration-Resistant in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Baratchian, M; Berk, M; Chakraborty, AA; Chakravarthy, A; Chan, TA; de Bono, J; De Carvalho, DD; Guerinot, A; Khalighi, S; Li, J; Makarov, V; Sharifi, N; Silverman, RH; Stark, GR; Tiwari, R; Varadan, V; Yuan, W1
Bagci-Onder, T; Cingöz, A; Kaplan, A; Kawamura, A; Lack, NA; McCullagh, J; Morova, T; Önder, T; Pires, E; Saraç, H1
Asberry, AM; Beketova, E; Chen, X; Deng, X; Elzey, BD; Fang, S; Hu, CD; Huang, J; Li, C; Liu, S; Malola, J; Owens, JL; Pili, R; Ratliff, TL; Wan, J; Zhang, Q1
Allen, A; Cottard, F; Einsle, O; Greschik, H; Hermann, B; Hornung, V; Imhof, A; Jung, M; Maurer, J; Metzger, E; Obier, N; Offermann, A; Perner, S; Preca, BT; Schmidt, A; Schüle, R; Sum, M; Ulferts, S; Urban, S; Wang, S; Willmann, D1
Choi, H; Kim, EJ; Lee, SH; Um, SJ1

Other Studies

5 other study(ies) available for isomethyleugenol and Prostatic Neoplasms, Castration-Resistant

ArticleYear
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2022, 05-24, Volume: 119, Issue:21

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; DNA Methylation; Drug Resistance, Neoplasm; Gene Silencing; Humans; Interferons; Male; Methylation; Nitriles; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer.
    Oncogene, 2020, Volume: 39, Issue:10

    Topics: Arginase; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Code; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Oxidoreductases; PC-3 Cells; Prostatic Neoplasms, Castration-Resistant; Protein Processing, Post-Translational

2020
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.
    Cancer research, 2020, 11-15, Volume: 80, Issue:22

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Enlargement; Disease Progression; Down-Regulation; Epigenesis, Genetic; Gene Expression Profiling; Gene Knockdown Techniques; Heterografts; Humans; Ion Channels; Male; Methylation; Mice; Neoplasm Transplantation; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Protein-Arginine N-Methyltransferases; Receptors, Androgen; Receptors, Histamine H2; Receptors, Histamine H3

2020
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
    Nature structural & molecular biology, 2019, Volume: 26, Issue:5

    Topics: Cell Line, Tumor; Cell Proliferation; Dimerization; Histones; Humans; Lysine; Male; Methylation; Methyltransferases; Prostatic Neoplasms, Castration-Resistant; Site-Specific DNA-Methyltransferase (Adenine-Specific)

2019
CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells.
    Cancer letters, 2016, 07-01, Volume: 376, Issue:2

    Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cullin Proteins; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histones; Humans; Male; Methylation; Nitriles; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Receptors, Androgen; RNA Interference; Signal Transduction; Tosyl Compounds; Transcription, Genetic; Transfection

2016